– USA, CA – CohBar, Inc. (NASDAQ: CWBR), a clinical-stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the appointment of Dr.…
– USA, PA – iECURE, inc. a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet need, today announced the appointment of Brian Di Donato to its Board of Directors.…
– USA, PA – PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, today announced the appointment of Bill Humphries to its board of directors and as a member of the compensation committee.…
– USA, MA – Mediar Therapeutics today announced the appointment of Simon Sturge to its Board of Directors as Executive Chairman, bringing extensive experience in both large pharmaceutical operations and biopharma startups to Mediar as it advances a novel platform technology focused on the myofibroblast, a cell that is a key driver in fibrosis pathology.…
– UK, London – SpectrumX, UK-based healthcare, and pharmaceutical company, today announced the upcoming appointment of Aziz McMahon to its Board of Directors as Executive Chairman, focusing on investor relations, corporate governance, and the formulation of the new ESG policy.…